Fluorinated Polymer Mediated Transmucosal Peptide Delivery for Intravesical Instillation Therapy of Bladder Cancer

Abstract

Surgical intervention combined with intravesical instillation of chemotherapeutics to clear residual cancer cells after operation is the current standard treatment method for bladder cancer. However, the poor bioavailability of active pharmaceutical ingredients for bladder cancer cells on account of the biological barriers of bladder mucosa, together with significant side effects of currently used intravesical medicine, have limited the clinical outcomes of localized adjuvant therapy for bladder cancer. Aiming at improved intravesical instillation therapy of bladder cancer, a fluorinated polyethylenimine (F‐PEI) is employed here for the transmucosal delivery of an active venom peptide, polybia‐mastoparan I (MPI), which shows selective antiproliferative effect against various bladder cancer cell lines. Upon simple mixing, MPI and F‐PET would coassemble to form stable nanoparticles, which show greatly improved cross‐membrane and transmucosal penetration capacities compared with MPI alone or nonfluorinated MPI/PEI nanoparticles. MPI/F‐PEI shows higher in vivo tumor growth inhibition efficacy for local treatment of a subcutaneous tumor model. More excitingly, as further demonstrated in an orthotopic bladder cancer model, MPI/F‐PEI offers remarkably improved therapeutic effects compared to those achieved by free MPI or the first‐line bladder cancer drug mitomycin C. This work presents a new transmucosal delivery carrier particularly promising for intravesical instillation therapy of bladder cancer.

Aminoglycoside‐Based Biomaterials: From Material Design to Antibacterial and Gene Delivery Applications

“…[ 105–108 ] These molecules can assemble into various structures such as micelles, nanoparticles, vesicles, and fibers, and have attracted great interest in biomedical applications. [ 109–115 ] Cationic lipids, one of the typical amphiphiles with positively charged headgroups, are commonly used nonviral vectors for gene delivery. [ 116,117 ] Notably, the multiple amino groups of aminoglycosides allowed these molecules to act as the head groups of cationic lipids.…”

Design of polymers for siRNA delivery: Recent progress and challenges

“…[155,157] The "proton-sponge" hypothesis was supported by cationic polymers such as PEI [158,159] and PAMAM dendrimers, [102] the most widely used cationic polymers in cytosolic biomacromolecule delivery. [160][161][162][163][164][165][166][167][168][169][170] Besides the "proton-sponge" effect, high pH-buffering polymers may facilitate endosomal escape by increased membrane disruption. The pH-buffering groups such as tertiary amine and imidazole with a pKa around physiological pH will be protonated when the pH drops in endosome, which will enhance the interactions of polymers with endosomal membranes.…”

<p>Extracellular Vesicles – Advanced Nanocarriers in Cancer Therapy: Progress and Achievements</p>

“…6 Several types of artificial NPs like liposomes, micelles, dendrimer, carbon nanotube, polymeric nanoparticles, magnetic nanoparticles, etc have been made and used in delivering various anticancer drugs. [7][8][9][10][11] Compared to traditional administration methods, such as oral administration or intravenous administration of free drug, NPs are able to deliver high doses of therapeutic drugs into the tumor site while bypassing healthy cells because of their enhanced permeability and retention (EPR) effect. 12 However, there are inevitable disadvantages of artificial NPs which limited their clinical application.…”